Skip to main content
Log in

Asthma bronchiale

Update 2006

Bronchial asthma. Update 2006

  • CME Weiterbildung · Zertifizierte Fortbildung
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Asthma bronchiale bleibt mit einer Prävalenz von 5% für Erwachsene und 10% für Kinder in Deutschland eine häufige Erkrankung. Neuere zellbiologische Daten zeigen eine getrennte Steuerung der Allergie (Interleukin-4- (IL-4-) Pfad) und der eosinophilen Asthma-Entzündung (IL-5-Pfad). Beides muss therapeutisch angegangen werden. Um ein irreversibles bronchiales Remodeling zu verhindern, ist eine frühzeitige Diagnose und konsequente Therapie entscheidend. Ein Asthma bronchiale gilt als gesichert, wenn der anfallsweise Krankheitscharakter nachgewiesen wird und sich eine zumindest intermittierende obstruktive Ventilationsstörung zeigt, die gut auf kurzwirksame β2-Adrenergika anspricht. Die heutige Asthmatherapie ist in vielen Studien gesichert (Evidenzlevel A) und beruht auf einem Stufenplan, der die therapeutischen Maßnahmen nach 4 Schweregraden gliedert. Darunter sind die meisten Patienten weitgehend beschwerdefrei, nächtliche Attacken sind heute eine Seltenheit. Neue Medikamente sollen verbliebene therapeutische Schwachstellen schließen. Antileukotriene und Anti-IgE-Antikörper können zur Reduktion der notwendigen Kortikosteroide beitragen. Pharmaka, die in die IL-4- oder IL-5-Steuerung eingreifen oder das Remodeling verhindern helfen, sind in Entwicklung.

Abstract

Bronchial asthma, with a prevalence in Germany of 5% among adults and 10% among children, remains a frequent disease. Newer cell biological data show a separate regulation of the allergy (interleukin 4, IL-4, pathway) and of the eosinophilic inflammation in asthma (IL-5 pathway). Both conditions require a therapeutic approach. To prevent irreversible bronchial remodeling, early diagnosis and targeted therapy are decisive. Bronchial asthma is regarded as evident when the paroxysmal character of the disease is confirmed and an—at least intermittent—obstructive ventilation disorder is apparent which responds well to short-acting β2-adrenergic agents. Current asthma treatment has been assured in many studies (evidence level A) and is based on therapy in stages which classifies therapeutic measures depending on four grades of severity. Accordingly, most patients are largely without complaints, and nocturnal attacks are now rare. New medications are intended to overcome any remaining therapeutic weak points. Antileukotrienes and anti-IgE antibodies can contribute to reducing the necessary corticosteroids. Pharmaceutical agents that intervene in the IL-4 or IL-5 regulation or prevent remodeling are being developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8

Literatur

  1. Abramson MJ, Puy RM, Weiner JM (2003) Allergen immunotherapy für asthma. Cochrane Database Syst Rev 4: CD001186

    PubMed  Google Scholar 

  2. Barnes PJ (2003) Pathophysiology of asthma. Eur Respir Mon 23: 84–113

    Google Scholar 

  3. Bel EH, Chanez P (2003) Diagnosis and assessment of asthma. Eur Respir Mon 23: 180–194

    Google Scholar 

  4. Bousquet J, Lockey R, Malling H (1998) WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53: Suppl 54

    Google Scholar 

  5. Bousquet J, Demoly P, Michel FB (2003) Eur Respir Mon 23: 409–428

    Google Scholar 

  6. Castro-Rodriguez JA, Holberg CJ, Morgan WJ et al. (2001) Increased incidence of asthmalike symptoms in girls who become overweight or obese during the school years. Am J Respir Crit Care Med 163: 1334–1349

    Google Scholar 

  7. Chung KF, Stirling RG, Chanez P, Godard P (2003) Severe therapy resistant asthma. Eur Respir Mon 23: 312–338

    Google Scholar 

  8. Cook DG, Strachan DP (1999) Health effects of passive smoking: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax 54: 357–366

    PubMed  Google Scholar 

  9. Corrigan CJ (1995) Elevated IL-4 secretion by T-lymphocytes: a feature of atopy or asthma? Clin Exp Allergy 25: 485–487

    Article  PubMed  Google Scholar 

  10. Dal Negro RW, Aubier M (2003) Bronchial asthma and gastro-oesophageal reflux. Eur Respir Mon 23: 260–277

    Google Scholar 

  11. Ehnert B, Lau-Schauendorf S, Weber A et al. (1992) Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 90: 135–138

    PubMed  Google Scholar 

  12. Fabbri LM, Romagnoli M, Richeldi L, Olivieri D (2003) Asthma versus chronic obstructive pulmonary disease. Eur Respir Mon 23: 195–210

    Google Scholar 

  13. Fahy JV, Fleming HE, Wong HH (1997) The effect of an anti-IgE monoclonal antibody on the early and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 155: 1828–1834

    PubMed  Google Scholar 

  14. Frew AJ (2003) Allergic basis of asthma. Eur Respir Mon 23: 74–83

    Google Scholar 

  15. Gibson PG, Henry RL, Coughlan JL (2003) Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 1: CD0011496

    Google Scholar 

  16. Gross NJ (1980) What is this thing called love? – or, defining asthma. Am Rev Respir Dis 121: 203–204

    Google Scholar 

  17. Holgate ST (2004) Lessons learnt from the epidemic of asthma. QJM 97: 247–257

    Article  PubMed  Google Scholar 

  18. Hollowy JW, Jongepier H, Beghé B et al. (2003) The genetics of asthma. Eur Repir Mon 23: 26–56

    Google Scholar 

  19. Homa DM, Mannino DM, Lara M (2000) Asthma mortality in US Hispanics of Mexican, Puerto Rican and Cuban heritage, 1990–1995. Am J Respir Crit Care Med 161: 504–509

    PubMed  Google Scholar 

  20. Humbert M, Kay AB (2003) Chronic inflammation in asthma. Eur Repir Mon 23: 126–137

    Google Scholar 

  21. Illi S, von Mutius E, Bergmann R et al. (2001) Upper respiratory tract infections in the first year of life and asthma in children up to the age of 7 years. BMJ 322: 390–395

    Article  PubMed  Google Scholar 

  22. Johnston SL (2005) Impact of viruses on airway disease. Eur Respir Rev 14: 57–61

    Google Scholar 

  23. Kabesch M, Schaal W, Nicolai T, von Mutius E (1999) Lower prevalence of asthma and atopy in Turkish children living in Germany. Eur Respir J 13: 577–582

    Article  PubMed  Google Scholar 

  24. Kogevinas M, Anto JM, Sunyer J (1999) Occupational asthma in Europe and other industrialised areas: a population based study. European Community Respiratory Health Survey Study Group. Lancet 22: 1750–1754

    Article  Google Scholar 

  25. Kramer U, Heinrich J, Wjst M, Wichmann HE (1999) Age of entry to day nursery and allergy in later childhood. Lancet 353: 450–454

    Article  PubMed  Google Scholar 

  26. Kroegel C, Buhl B, Gillissen A, Petro W (2005) Asthma bronchiale versus chronisch-obstruktive Lungenkrankheit (COPD). Dtsch Med Wochenschr 130: 812–818

    Article  PubMed  Google Scholar 

  27. Lilly CM (2005) Diversity of asthma: Evolving concepts of pathophysiology and lessons from genetics. J Allergy Clin Immunol 115: S526–S531

    Article  PubMed  Google Scholar 

  28. McFadden ER (2003) Acute severe asthma. Am J Respir Crit Care Med 168: 740–759

    Article  PubMed  Google Scholar 

  29. Mapp CE, Saetta M, Mastrelli P, Fabbri L (1999) Occupational asthma. Eur Respir Mon 11: 255–285

    Google Scholar 

  30. Mielck A, Reitmeir P, Wjst M (1996) Severity of childhood asthma by socio-economic status. Int J Epidemiol 18: 888–890

    Google Scholar 

  31. Murphy VE, Gibson PG, Smith R, Clifton VL (2005) Asthma during pregnancy: mechanisms and treatment implications. Eur Respir J 25: 731–750

    Article  PubMed  Google Scholar 

  32. Nationale Versorgungs-Leitlinie Asthma (2005) Fassung September 2005. http://www.asthma.versorgungsleitlinien.de

  33. Osur SL (2005) The management of asthma and rhinitis during pregnancy. J Womens Health 14: 263–276

    Article  Google Scholar 

  34. Panhuysen CI, Bleecker ER, Koeter GH et al. (1998) Characterization of obstructive airway disease in family members of probands with asthma. An algorithm for the diagnosis of asthma. Am J Respir Crit Care Med 157: 1734–1742

    PubMed  Google Scholar 

  35. Pearce N, Douwes J, Beasley R (2000) Is allergen exposure the major primary cause of asthma? Thorax 55: 424–431

    Article  PubMed  Google Scholar 

  36. Peebles RS (2004) Viral infections, atopy, and asthma: Is there a causal relationship. J Allergy Clin Immunol 113: S15-S18

    Article  PubMed  Google Scholar 

  37. Riedler J, Braun-Fahrlander C, Eder W (2001) Early life exposure to farming provides protection against the development of asthma and allergy. Lancet 358: 1129–1133

    Article  PubMed  Google Scholar 

  38. Ronmark E (1999) Asthma – incidence, remission and risk factors. Umeå University Dissertations, New Series No. 630

  39. Salvi S, Frew A, Holgate ST (1999) Is diesel exhaust a cause for increasing allergies? Clin Exp Allergy 29: 4–8

    Article  PubMed  Google Scholar 

  40. Sears MR, Greene J, Flannery EM, Herbison GP (2000) Early childhood exposure to pets in the home, sensitation and risk of asthma. Eur Respir J 16 [Suppl]: 555S

    Article  Google Scholar 

  41. Sheffer AL (1995) Global initiative for asthma. NHLBI/WHO workshop report, National Institutes of Health, National Heart, Lung and Blood Institute, Publication No. 95-3659

  42. Siroux V, Pin I, Oryszczyn MP et al. (2000) Relationships of active smoking to asthma and asthma severitiy in the EGEA study. Eur Respir J 15: 470–477

    Article  PubMed  Google Scholar 

  43. Skobeloff EM, Pivey WH, St. Clair SS, Schoffstall JM (1992) The influence of age and sex on asthma admissions. JAMA 268: 3437–3440

    Article  PubMed  Google Scholar 

  44. Sunyer J, Spix C, Quenel P (1997) Urban air pollution and emergency admission for asthma in European cities: the APHEA projects. Thorax 52: 760–765

    PubMed  Google Scholar 

  45. Szczeklik A, Picado C (2003) Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111: 913–921

    Article  PubMed  Google Scholar 

  46. Viegi G, Annesi I, Matteeli G (2003) Epidemiology of asthma. Eur Respir Mon 23: 1–25

    Google Scholar 

  47. von Mutius E, Fritzsch C, Weiland SK et al. (1992) Prevalence of asthma and allergic disorders among children in united Germany. A descriptive comparison. BMJ 305: 1395–1399

    PubMed  Google Scholar 

  48. von Mutius, Weiland SK, Fritzsch C et al. (1998) Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 351: 862–866

    Article  PubMed  Google Scholar 

  49. von Mutius E, Sears MR (2003) Risk factors for development of asthma. Eur Respir Mon 23: 57–73

    Google Scholar 

  50. Wilkonson J, Grimley S, Collins A et al. (1998) Linkage of asthma to markers on chromosome 12 in a sample of 240 families using quantitative phenotypes scores. Genomics 53: 251–259

    Article  PubMed  Google Scholar 

  51. World Health Organization (2000) Bronchial asthma. WHO fact sheet No. 206. http://www.who.int/inf-fs/en/fact206.html

Download references

Interessenkonflikt

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Schmidt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt, M. Asthma bronchiale. Internist 47, 835–852 (2006). https://doi.org/10.1007/s00108-006-1671-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-006-1671-2

Schlüsselwörter

Keywords

Navigation